479 third-party lab reports publishedVolume pricing on every peptide, applied automatically in the cart: 3% off 2–3 · 8% off 4–5 · 12% off 6–7 · 15% off 8–9 · 20% off 10–19 · 25% off 20–29 · 30% off 30–39 · 35% off 40+ units · solvents and lab supplies excluded99.65% median purity across 272 lots257 / 257 lots pass sterility479 third-party lab reports publishedVolume pricing on every peptide, applied automatically in the cart: 3% off 2–3 · 8% off 4–5 · 12% off 6–7 · 15% off 8–9 · 20% off 10–19 · 25% off 20–29 · 30% off 30–39 · 35% off 40+ units · solvents and lab supplies excluded99.65% median purity across 272 lots257 / 257 lots pass sterility
Batch 1668 · tested December 31, 2025 (308 days ago) · released May 25, 2026 Discontinued variant
All tests passed
Batch
#1668 10 tests
Mass
12mg+12mg+12mg (36mg Total)
Purity
>99.80%
Issuing lab accreditation
Vanguard · ISO 17025:2017 / A2LA #6377.01.01
1 unit tested for purity: >99.80% as printed
Conformity: Not assessable — every reported unit passed on all 8 test rows · QA approval corroborates: Vanguard Laboratory, Tori Johnson, Operations Manager, 2025-12-31
Compound is a triple blend: BPC-157 (11.29 mg), TB-500 (11.81 mg), Cartalax (11.12 mg) out of 12 mg each labeled amount. Sterility confirmed by two independent labs and methods.
8 results on the report · 5 rows computed from the per-unit values · 2 labs · each test used up to 1 vial from this lot (rows are not added together) · every row names the chapter or house rule it follows
✓PurityWithin limits
>99.80 · 1 unit · USP <621> (procedural chapter)
–Purity consistency between unitsSingle measurement
1 unit printed (>99.80%) · a between-unit spread needs two or more measured units
11.12 mg · 1 unit · USP <621> (procedural chapter)
–Content consistency between units · TB-500Single measurement
1 unit printed (11.81 mg) · a between-unit spread needs two or more measured units
–Content consistency between units · BPC-157Single measurement
1 unit printed (11.29 mg) · a between-unit spread needs two or more measured units
–Content consistency between units · CartalaxSingle measurement
1 unit printed (11.12 mg) · a between-unit spread needs two or more measured units
✓Heavy metalsWithin limits
all non-detect · 1 unit · dose-scaled limits derived from USP <232> (limits chapter)
–Residual solventsNot on this lot's panel
not on this report · this batch was tested to our earlier standard; newer batches get all 15 tests
–TFA residualNot on this lot's panel
not on this report · this batch was tested to our earlier standard; newer batches get all 15 tests
✓EndotoxinsWithin limits
12.83 EU/mg · 1 unit · USP <85> (procedural chapter)
–Container closureNot on this lot's panel
not on this report · this batch was tested to our earlier standard; newer batches get all 15 tests
–SolubilityNot on this lot's panel
not on this report · this batch was tested to our earlier standard; newer batches get all 15 tests
✓SterilityPass
1 of 1 pass · 1 unit · USP <71> (procedural chapter)
✓SterilityPass
1 of 1 pass · 1 unit · USP <71> (reference) · a rapid viability test used as an alternative to the USP <71> growth test; USP <1223> is the validation framework (informational chapter) · at Eagle Analytical
–ConformityNot assessable
every reported unit passed on all 8 test rows · QA approval corroborates: Vanguard Laboratory, Tori Johnson, Operations Manager, 2025-12-31 · house check · agreement across all tests, unit to unit; QA approval corroborates
A chapter number names the method or limit a result follows; it does not describe the product. Chapters below 1000 are procedures or limits; 1000-series chapters are informational. USP <905> is the compendial test for between-unit uniformity: it assays 10 units, so a 3-unit certificate cannot yield its acceptance value — the content row is a house check with <905> named as the reference only.
Combined report · Batch 1668
One file holding the Vanguard Laboratory and Eagle Analytical Services reports for this batch, assembled by our quality team from the labs' files.